ArticleScientific reports2026
Modified Smith predictor-based fuzzy self-tuning FOPID controller for mean arterial pressure regulation.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The simultaneous regulation of hemodynamic variables, particularly mean arterial pressure (MAP) and cardiac output (CO), is challenging due to time-varying delays, cross-coupling effects, and parameter uncertainty inherent in drug-response dynamics. A robust control framework is developed that integrates a fractional-order PID (FOPID) controller with a fuzzy logic self-tuning mechanism (FLST) and a modified Smith predictor (MSP) to enable adaptive gain scheduling and explicit compensation of bounded delays. The patient is modeled as a two-by-two first-order time-delay MIMO system actuated by sodium nitroprusside (SNP) and dopamine (DPM). Besides, transport and recirculation delays are assumed variable and conservatively bound at 60 s. While the inclusion of fractional orders provides additional degrees of freedom, resulting in improved transient performance and enhanced steady-state accuracy, the MSP maintains stability and tracking performance in the presence of time-varying delays. Extensive simulation studies under nominal and uncertain conditions demonstrate faster rise and settling times, reduced overshoot, and lower integral error indices than those of conventional PID and fractional-order PID controllers. Robustness to inter-patient variability in the presence of disturbances and noise measurement, and clinically acceptable performance, indicating feasibility for real-time closed-loop drug infusion. Overall, the proposed FLST-FOPID-MSP architecture offers a promising and safety-oriented solution for automated MAP and CO regulation and motivates future comparisons with predictive and -based control strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.